Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Johnson & Johnson buy tbackenh

Johnson & Johnson
Start price
€87.59
30.06.15 / 50%
Target price
€95.00
16.07.15
Performance (%)
6.07%
End price
€92.91
16.07.15
Summary
This prediction ended on 16.07.15 with a price of €92.91. With a performance of 6.07%, the BUY prediction by tbackenh for Johnson & Johnson closed with a slight gain. tbackenh has 50% into this prediction

Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.

Performance without dividends (%)
Name 1w 1m 1y 3y
Johnson & Johnson 2.134% 2.134% -6.813% 3.296%
iShares Core DAX® 0.000% -2.064% 13.111% 16.685%
iShares Nasdaq 100 0.626% -2.884% 37.744% 43.441%
iShares Nikkei 225® 1.568% -5.892% 19.592% 4.617%
iShares S&P 500 0.334% -2.281% 27.745% 41.046%

According to tbackenh what are the pros and cons of Johnson & Johnson for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
Cons

Comments by tbackenh for this prediction

In the thread Johnson & Johnson diskutieren
Prediction Buy
Perf. (%) 6.07%
Target price 95.000
Change
Ends at 16.07.15

Johnson & Johnson

Johnson & Johnson ist ein weltweit tätiger amerikanischer Pharmazie- und Konsumgüterhersteller mit Hauptsitz in New Brunswick im US-Bundesstaat New Jersey. Das Unternehmen ist im Dow Jones Industrial Average gelistet. Je nach Betrachtungsweise, d. h. inwieweit man alle Geschäftsbereiche einbezieht, war Johnson & Johnson 2012 mit 67,2 Mrd. US$ Umsatz – vor Pfizer – das größte Healthcareunternehmen der Welt. Betrachtet man nur das reine Pharmageschäft, steht JNJ 2012 an achter Stelle.

Auch 2015 wird die Gesundheitsbranche für mich zu den Gewinnern zählen. Es gibt viele gute Gründe, z.B. Demographie (Menschen in den Industrieländern werden immer älter), die letztlich für weitere Kursfantasie sorgen dürften.

tbackenh 
0
Report Share
30.06.15
Prediction Buy
Perf. (%) 6.07%
Target price 95.000
Change
Ends at 16.07.15

(Vom Mitglied beendet)

tbackenh 
0
Report Share
16.07.15

Stopped prediction by tbackenh for Johnson & Johnson

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€174.42
27.04.22
€190.00
27.04.23
-15.38%
27.04.23

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
tbackenh 
27.04.22 100%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€125.49
21.11.17
€135.30
06.08.18
-3.54%
06.08.18

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
tbackenh 
16.08.19 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€86.15
28.11.14
€92.00
23.01.15
6.79%
23.01.15

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
tbackenh 
16.08.19 50%